Подмороженная трансплантация островков в эпидидимальной жировой клетке диабетических мышей

Overview

This protocol demonstrates murine islet isolation and seeding onto a decellularized scaffold, followed by transplantation into diabetic mice. The study highlights the potential of scaffold-supported islets to reverse hyperglycemia.

Key Study Components

Area of Science

• Biomedical Engineering
• Diabetes Research
• Islet Transplantation

Background

• Type 1 diabetes is primarily managed with insulin injections.
• Islet transplantation can provide better blood glucose control.
• Challenges include the need for high-quality islets and poor engraftment efficiency.
• Decellularized scaffolds may improve islet survival and function post-transplant.

Purpose of Study

• To demonstrate the process of islet isolation and transplantation.
• To evaluate the survival of islets in a scaffold at the transplantation site.
• To assess the ability of transplanted islets to reverse hyperglycemia in diabetic mice.

Methods Used

• Isolation of murine islets from pancreatic tissue.
• Seeding islets onto a decellularized scaffold.
• Transplantation of scaffold-supported islets into the epididymal fat pad of diabetic mice.
• Monitoring islet survival and blood glucose levels post-transplant.

Main Results

• Islets survived at the transplantation site.
• Transplanted islets effectively reversed hyperglycemia in STZ-induced diabetic mice.
• Scaffold support enhanced islet engraftment and function.
• The protocol provides a viable method for islet transplantation research.

Conclusions

• Scaffold-supported islet transplantation shows promise for diabetes treatment.
• Further research is needed to optimize islet quality and engraftment.
• This method could potentially improve clinical outcomes for diabetic patients.

Frequently Asked Questions